Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_470526cc244120289562c93a5b28e043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3838435d45bfa850c0d598b992a59db6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cce4f06adcce98c6e382d0518e8c3b35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a194ac1a21038789ec10adfb7e38130 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0381 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0647 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0789 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
filingDate |
2004-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaca34b3683439d666f0d211df5ff123 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11f82dfa80068913db6e6d1fd0cec5a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd232bbd0931daeb2a141e8eb2604876 |
publicationDate |
2005-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005016367-A1 |
titleOfInvention |
Therapeutic preparation for hematopoietic disease |
abstract |
Therapeutic preparations for hematopoietic diseases comprising synoviolin, whose isolation as a synovial cell protein has been reported, and a gene thereof as effective ingredients; a therapeutic method comprising administering the protein or relevant polynucleotide; etc. There are further provided a synoviolin-homo-deficient animal and cells derived from the animal as a model for hematopoietic diseases and is provided a method of screening a therapeutic agent for hematopoietic diseases with the use of the model. |
priorityDate |
2003-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |